Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meristem’s BIO-CAPSULE™ biologicals delivery platform is commercial, enabling live microbials and chemical actives use at scale across more than 10 million acres. Products are marketed for nitrogen management, residue breakdown, stress mitigation, and seed treatment replacement. The product portfolio shows successful market adoption in row crops, especially corn and soybeans, with support for measurable farm ROI.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meristem Crop Performance.